Variant report
Variant | esv3489634 |
---|---|
Chromosome Location | chr11:101443892-101446490 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs549520858 | chr11:101443910-101443911 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs574407117 | chr11:101443912-101443913 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs191391125 | chr11:101443970-101443971 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs559292971 | chr11:101443972-101443973 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs183632387 | chr11:101443985-101443986 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs11493972 | chr11:101443992-101443993 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs138621572 | chr11:101444036-101444037 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs200777346 | chr11:101444037-101444038 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs188674270 | chr11:101444048-101444049 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs575614869 | chr11:101444076-101444077 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs142689382 | chr11:101444096-101444097 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs561078717 | chr11:101444102-101444103 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs375741417 | chr11:101444127-101444128 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs78566629 | chr11:101444237-101444238 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs559684436 | chr11:101444245-101444246 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs528323333 | chr11:101444260-101444261 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs191919774 | chr11:101444273-101444274 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs7128403 | chr11:101444279-101444280 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs376401132 | chr11:101444335-101444336 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs143461100 | chr11:101444377-101444378 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs530497982 | chr11:101444380-101444381 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs11224873 | chr11:101444532-101444533 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs544108082 | chr11:101444541-101444542 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs567113757 | chr11:101444651-101444652 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs536238883 | chr11:101444652-101444653 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs375584806 | chr11:101444675-101444676 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs150134652 | chr11:101444678-101444679 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs80170162 | chr11:101444685-101444686 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs58766729 | chr11:101444688-101444689 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs11224874 | chr11:101444689-101444690 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs57878426 | chr11:101444697-101444698 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs72976319 | chr11:101444722-101444723 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs372635385 | chr11:101444727-101444728 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs561483708 | chr11:101444777-101444778 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs10895144 | chr11:101444783-101444784 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs386756872 | chr11:101444788-101444789 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs10895145 | chr11:101444790-101444791 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs10895146 | chr11:101444805-101444806 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs555037253 | chr11:101444838-101444839 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs574787593 | chr11:101444843-101444844 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs530869044 | chr11:101444847-101444848 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs373571426 | chr11:101444859-101444860 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs564197947 | chr11:101444910-101444911 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs540610984 | chr11:101444963-101444964 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs11224875 | chr11:101444978-101444979 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs11224876 | chr11:101445006-101445007 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs566834805 | chr11:101445040-101445041 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs369415874 | chr11:101445061-101445062 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs61918375 | chr11:101445073-101445074 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs565027188 | chr11:101445090-101445091 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Gastric cancer | 17908304 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Wilms tumour | 21544195 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Cancer | 21637783 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Cervical cancer | 21063398 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Liposarcoma | 21253554 | CNVD |
Neuroblastoma | 18923524 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Cancer | 16751803 | CNVD |
Seminomas | 18059402 | CNVD |
Cervical cancer | 21062161 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 22429812 | CNVD |
Breast cancer | 16608533 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Hepatocellular carcinoma | 16785998 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21858162 | CNVD |
Breast cancer | 21785460 | CNVD |
Melanoma | 22183965 | CNVD |
Breast cancer | 21958427 | CNVD |
Lung cancer | 18438408 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Breast cancer | 17133270 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 17603634 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Basal cell lymphoma | 16790693 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Breast cancer | 21364760 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Mental retardation | 19966786 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Mantle cell lymphoma | 19029149 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Ovine squamous-cell carcinoma | 17599052 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Cancer | 20164919 | CNVD |
Breast cancer | 22522925 | CNVD |
Cancer | 20164920 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:101426400-101447600 | Weak transcription | IMR90 fetal lung fibroblasts Cell Line | lung |
2 | chr11:101437000-101444400 | Weak transcription | NHDF-Ad | bronchial |
3 | chr11:101438400-101445400 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
4 | chr11:101443800-101446000 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
5 | chr11:101444200-101445000 | Enhancers | NHLF | lung |
6 | chr11:101444400-101444800 | Enhancers | Fetal Lung | lung |
7 | chr11:101444400-101449200 | Enhancers | NHDF-Ad | bronchial |
8 | chr11:101444800-101446000 | Weak transcription | Fetal Lung | lung |
9 | chr11:101445000-101446000 | Weak transcription | NHLF | lung |
10 | chr11:101445400-101447800 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
11 | chr11:101445800-101446600 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
12 | chr11:101445800-101447000 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
13 | chr11:101445800-101447400 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
14 | chr11:101446000-101446800 | Enhancers | Fetal Lung | lung |
15 | chr11:101446000-101448200 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
16 | chr11:101446000-101448600 | Enhancers | NHLF | lung |
17 | chr11:101446400-101446800 | Enhancers | HUES48 Cell Line | embryonic stem cell |
18 | chr11:101446400-101446800 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
19 | chr11:101446400-101447200 | Enhancers | HUES64 Cell Line | embryonic stem cell |
20 | chr11:101446400-101447200 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
21 | chr11:101446400-101447800 | Enhancers | Colon Smooth Muscle | Colon |